HomeInsightsStock Comparison

Akums Drugs Pharmaceuticals Ltd vs Solara Active Pharma Sciences Ltd Stock Comparison

Akums Drugs Pharmaceuticals Ltd vs Solara Active Pharma Sciences Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Akums Drugs & Pharmaceuticals Ltd is ₹ 537.8 as of 22 Jul 15:30.
  • The P/E Ratio of Akums Drugs & Pharmaceuticals Ltd changed from 21.5 on March 2025 to 21.5 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Solara Active Pharma Sciences Ltd changed from 10.4 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The Market Cap of Akums Drugs & Pharmaceuticals Ltd changed from ₹ 7469 crore on March 2025 to ₹ 7469 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Solara Active Pharma Sciences Ltd changed from ₹ 1190 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The revenue of Akums Drugs & Pharmaceuticals Ltd for the Mar '25 is ₹ 1081 crore as compare to the Dec '24 revenue of ₹ 1029 crore. This represent the growth of 5.01% The revenue of Solara Active Pharma Sciences Ltd for the Mar '25 is ₹ 278.96 crore as compare to the Dec '24 revenue of ₹ 301.8 crore. This represent the decline of -7.57%.
  • The ebitda of Akums Drugs & Pharmaceuticals Ltd for the Mar '25 is ₹ 119.68 crore as compare to the Dec '24 ebitda of ₹ 140.71 crore. This represent the decline of -14.95% The ebitda of Solara Active Pharma Sciences Ltd for the Mar '25 is ₹ 51.32 crore as compare to the Dec '24 ebitda of ₹ 59.17 crore. This represent the decline of -13.27%.
  • The net profit of Akums Drugs & Pharmaceuticals Ltd changed from ₹ -187 crore to ₹ 149.61 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Solara Active Pharma Sciences Ltd changed from ₹ -19.11 crore to ₹ -2.1 crore over 8 quarters. This represents a CAGR of -66.85% .
  • The Dividend Payout of Akums Drugs & Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Solara Active Pharma Sciences Ltd changed from 4.77 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Akums Drugs & Pharmaceuticals Ltd

  • Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC. Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
  • They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients.
  • Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services.
  • Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation.

About Solara Active Pharma Sciences Ltd

  • Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs).
  • The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets.
  • The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others.
  • It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches.

Akums Drugs & Pharmaceuticals Ltd News Hub

News

Akums Drugs & Pharmaceuticals AGM scheduled

Akums Drugs & Pharmaceuticals announced that the 21st Annual General Meeting(AGM) of the c...

Read more

29 May 2025 12:07

News

Akums Drugs & Pharmaceuticals announces board meeting date

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

20 May 2025 16:59

News

Akums Drugs & Pharmaceuticals to table results

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

01 Feb 2025 17:13

News

Akums Drugs drops as IT dept conducts search at its offices & units

'Income Tax Department conducted search under the Income Tax Act, 1961 at the offices and ...

Read more

22 Jan 2025 12:07

News

Akums Drugs rallies on inking pact to supply pharmaceutical formulations in Europe

The agreement is in line with Akums growth objective of expanding in European and other re...

Read more

24 Dec 2024 13:01

News

Akums Drugs ties up with Jagdale Inds for marketing of ready-to-drink nutritional beverages

This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in ...

Read more

26 Nov 2024 12:47

Solara Active Pharma Sciences Ltd News Hub

News

Solara Active Pharma Sciences to announce Quarterly Result

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

19 Jul 2025 10:30

News

Solara Active Pharma's Ambernath facility clears USFDA inspection

The Agency with their designated investigator inspected the facility from 5th to 9th May 2...

Read more

12 May 2025 08:36

News

Solara Active Pharma Sciences to conduct board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

07 May 2025 17:24

News

Solara Active Pharma Sciences to convene board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

27 Mar 2025 10:23

News

Solara Active Pharma Sciences to hold board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

22 Mar 2025 10:11

News

Solara Active Pharma Sciences to incorporate wholly owned subsidiary

Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in rel...

Read more

07 Feb 2025 11:00

SWOT Analysis Of Solara Active Pharma Sciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Akums Drugs & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Solara Active Pharma Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Akums Drugs & Pharmaceuticals Ltd and Solara Active Pharma Sciences Ltd

Which company has a larger market capitalization, Akums Drugs & Pharmaceuticals Ltd or Solara Active Pharma Sciences Ltd?

Market cap of Akums Drugs & Pharmaceuticals Ltd is 8,464 Cr while Market cap of Solara Active Pharma Sciences Ltd is 2,964 Cr

What are the key factors driving the stock performance of Akums Drugs & Pharmaceuticals Ltd and Solara Active Pharma Sciences Ltd?

The stock performance of Akums Drugs & Pharmaceuticals Ltd and Solara Active Pharma Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Akums Drugs & Pharmaceuticals Ltd and Solara Active Pharma Sciences Ltd?

As of July 22, 2025, the Akums Drugs & Pharmaceuticals Ltd stock price is INR ₹537.8. On the other hand, Solara Active Pharma Sciences Ltd stock price is INR ₹673.75.

How do dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Solara Active Pharma Sciences Ltd compare?

To compare the dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Solara Active Pharma Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions